← Leaderboards
Steven Reese
Rarecyte, Inc.
$996,786
Attributed
$1,993,572
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2020–21$2M$1.5M$1M$500K$0
'20
'21
Funding mix
By agency
NIH$1,993,572 · 1
By mechanism
R44$1,993,572 · 1
Top collaborators
- Eric Kaldjian2 shared
Most similar at Rarecyte, Inc.
Same institution · by research overlap
- Eric Kaldjian$1,819,493
- Tad George$658,336
Others in their field
Other Emerging Leaders on “Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$169,304,044
- Yunda Huang · Fred Hutchinson Cancer Center$73,421,550
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Hanjoon Ryu$28,519,898
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
AntibodiesAntibody ConjugateAntigensArchitectureArchivesAutoimmunityBaseBiomarker DiscoveryBiotechnologyCancer DiagnosisCancer ModelCancer TypeCell CommunicationCell TypeCellular ImagingCheckpoint InhibitionClinically ActionableClinical ResearchClinical TrialsCohortCommunicable DiseasesComputer SoftwareData CollectionAnatomy